20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T72289 | Type II TRK inhibitor 1 | Trk receptor | |
Type II TRK Inhibitor 1 is a potent inhibitor targeting multiple tropomyosin receptor kinase (TRK) fusion protein variants as well as the wild type. It demonstrates notable antiproliferative effects on Ba/F3 cells expres... | |||
T61054 | Type II topoisomerase inhibitor 1 | ||
Type II topoisomerase inhibitor 1 is able to be used in the antibacterial area. Type II topoisomerase inhibitor 1 is a potent and selective inhibitor of E. coli DNA gyrase with a IC50 value of 1.7 nM as well as forms hyd... | |||
T9491 | Pyraclostrobin | Antibacterial , Antifungal | |
Pyraclostrobin is one of the most heavily used fungicides that inhibits mitochondrial complex III of fungal and mammalian cells. | |||
T13173 | TMPA | Others , AMPK | |
TMPA is a nuclear receptor Nur77 and LKB1 interaction antagonist. | |||
T12493 | PK68 | Others , RIP kinase | |
PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90 nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis. | |||
T9924 | Obinutuzumab | Obinutuzumab/afutuzumab | Others |
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. | |||
T9098 | DMG-PEG 2000 | DMG-PEG2000 | Others |
DMG-PEG 2000 (DMG-PEG2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG 2000 have been used in the development of lipid... | |||
T20029 | Buformin hydrochloride | NSC528218,NSC-528218,NSC 528218 | AMPK |
Buformin hydrochloride (NSC-528218) is a potent AMPK activator,an oral antidiabetic drug of the biguanide class. Buformin delays the absorption of glucose from the gastrointestinal tract increases insulin sensitivity and... | |||
T1615 | Irbesartan | SR-47436,BMS-186295 | Apoptosis , RAAS |
Irbesartan (SR-47436) is an Angiotensin 2 Receptor Blocker. The mechanism of action of irbesartan is as an Angiotensin 2 Receptor Antagonist. | |||
T1800 | GW788388 | GW 788388 | ALK , TGF-beta/Smad |
GW788388 is a potent and selective inhibitor of ALK5, also inhibits TGF-(beta) type II receptor and activin type II receptor activities. | |||
TQ0061 | CHZ868 | JAK | |
CHZ868 is a type II JAK inhibitor with potential antitumor activity that reverses the persistence of type I JAK inhibitors and can be used to study leukemia. | |||
T15603 | ITX5061 | ITX-5061 | HCV Protease , p38 MAPK |
ITX5061 is a type II inhibitor of p38 MAPK and scavenger receptor B1 (SRB1) antagonist for the study of hepatitis C virus infection. | |||
T2123 | LY2109761 | Autophagy , TGF-beta/Smad | |
LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2. | |||
T4268 | CHMFL-BMX-078 | BTK | |
CHMFL-BMX-078 is a highly potent and selective type II irreversible BMX kinase inhibitor with an IC50 of 11 nM. | |||
T0158 | Mitoxantrone dihydrochloride | Mitoxantrone 2HCl,Mitoxantrone hydrochloride,NSC-301739,mitozantrone dihydrochloride | Topoisomerase , PKC |
Mitoxantrone dihydrochloride (NSC-301739) is the hydrochloride salt of an anthracenedione antibiotic with antineoplastic activity. It is a type II topoisomerase inhibitor. | |||
T27643 | Izonsteride | LY-320236,LY320236,UNII-A5E8C36F34 | Reductase |
Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.Izonsteride is used in the treatment of oncology and genitourinary disorders, ... | |||
T63544 | RIPK3-IN-1 | ||
RIPK3-IN-1 is a type II RIPK3DFG-out site inhibitor (IC50: 9.1 nM) that inhibits RIPK1 (IC50: 5.5 μM) and RIPK2 (IC50>10 μM). RIPK3-IN-1 is a c-Met kinase inhibitor (IC50: 1.1 μM). | |||
T10800 | CHMFL-ABL-121 | Bcr-Abl | |
CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase (IC50s: 2 nM and 0.2 nM against purified inactive ABL wt and T315I kinase protein). | |||
T2153 | 1-NM-PP1 | PP1 Analog II,1 nM-PP1 | Serine/threonin kinase , CDK , Src |
1-NM-PP1 (PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors. | |||
T16333 | NKY80 | Adenylyl cyclase type V Inhibitor | Adenylyl cyclase |
NKY80 regulates the adenylyl cyclase catalytic activity in heart and lung tissues. NKY80 is a non-competitive inhibitor of adenylyl cyclase type V isoform (IC50s: 8.3 µM, 132 µM, and 1.7 mM for type V, III and II, respe... |